Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle (original) (raw)
Inhibitors of Plasmepsin II—potential antimalarial agents
Julien Grimont
Bioorganic & Medicinal Chemistry Letters, 2006
View PDFchevron_right
Plasmepsin 4-Deficient Plasmodium berghei Are Virulence Attenuated and Induce Protective Immunity against Experimental Malaria
Roberta Spaccapelo
The American Journal of Pathology, 2010
View PDFchevron_right
Inhibition of Plasmepsin V Activity Demonstrates Its Essential Role in Protein Export, PfEMP1 Display, and Survival of Malaria Parasites
Alan Cowman
Plos Biology, 2014
View PDFchevron_right
Plasmodium:Drug Discovery and Development—An Industrial Perspective
Dr. Robert Ridley
Experimental Parasitology, 1997
View PDFchevron_right
Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design
Christopher Thomas Flood
Bioorganic & Medicinal Chemistry Letters, 2011
View PDFchevron_right
Clearance of Drug-Resistant Parasites as a Model for Protective Immunity in Plasmodium Falciparum Malaria
Yacouba Cissoko
The American Journal of Tropical Medicine and Hygiene, 2003
View PDFchevron_right
Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region
Ilaria Russo
PLOS ONE, 2015
View PDFchevron_right
Malaria Journal BioMed Central
Marc Coosemans
2009
View PDFchevron_right
Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion
Ilaria Russo
Science (New York, N.Y.), 2017
View PDFchevron_right
Malaria: Patterns of relapse and resistance
Dr Muheet .Alam
Journal of King Saud University - Science, 2010
View PDFchevron_right
Suppression of Plasmodium MIF‐CD74 signaling protects against severe malaria
Alvaro Garcia junior
The FASEB Journal, 2021
View PDFchevron_right
A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress
Paco Pino
Science
View PDFchevron_right
Apical Surface Expression of Aspartic Protease Plasmepsin 4, a Potential Transmission-blocking Target of the Plasmodium Ookinete
John Dame
Journal of Biological Chemistry, 2010
View PDFchevron_right
Plasmepsin 4, the food vacuole aspartic proteinase found in all Plasmodium spp. infecting man
John Dame
Molecular and Biochemical Parasitology, 2003
View PDFchevron_right
Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies
Hamza Babiker
Expert Review of Anti-infective Therapy, 2009
View PDFchevron_right
Anti-Malarial Drug Development and Diffusion in an Era of Multidrug Resistance
Ellen Moors
Oxford University Press eBooks, 2020
View PDFchevron_right
Malaria and COVID-19: commonalities, intersections and implications for sustaining malaria control
Catherine Falade
Pan African Medical Journal, 2020
View PDFchevron_right
Malaria: What are the Needs for Diagnosis, Treatment and Control?
basha ayele
Biology and Medicine, 2016
View PDFchevron_right
Recent advances in identification of potential drug targets and development of novel drugs in protozoal diseases. Part IV. Apicomplexans and Plasmodium spp
Sherif Abaza
Parasitologists United Journal, 2022
View PDFchevron_right
A candidate antibody drug for prevention of malaria
Daniel Emerling
Nature Medicine, 2024
View PDFchevron_right
Preliminary in silico study of a novel paratransgenic weapon against malaria
Michelle Fidelia
Deleted Journal, 2024
View PDFchevron_right
Inter-relação do ritmo e da ação de drogas antimaláricas na infecção da malária de roedores
Piero Bagnaresi
View PDFchevron_right
Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor
Ben Dunn
Acta Crystallographica Section D Biological Crystallography, 2006
View PDFchevron_right
Prevention or treatment? The case of malaria
Jean-Claude Berthélemy
Economics Letters, 2015
View PDFchevron_right
Development of vaccines against malaria
Klavs Berzins
International Journal of Immunopharmacology, 1994
View PDFchevron_right
Malarial Subjects
Rohan Deb Roy
2017
View PDFchevron_right
Malaria vaccines: if at first you don't succeed…
David Roos
Trends in Parasitology, 2004
View PDFchevron_right
Treatment of Chronic Asymptomatic Plasmodium falciparum Infection Does Not Increase the Risk of Clinical Malaria Upon Reinfection
Didier Doumtabe
Clinical Infectious Diseases, 2016
View PDFchevron_right
Emergence of Undetectable Malaria Parasites: A Threat under the Radar amid the COVID-19 Pandemic?
abdulrahman mohammed
The American Journal of Tropical Medicine and Hygiene, 2020
View PDFchevron_right
Asymptomatic Natural Human Infections With the Simian Malaria Parasites Plasmodium cynomolgi and Plasmodium knowlesi
chanon kunasol
The Journal of Infectious Diseases, 2018
View PDFchevron_right
Role of Antibody Diversity in the Management of Malaria Parasite Invasion
Farouk Muhammad
2019
View PDFchevron_right
A protein interaction network of the malaria parasite Plasmodium falciparum
Sudhir Sahasrabudhe
Nature, 2005
View PDFchevron_right
Generation of an affinity matrix useful in the purification of natural inhibitors of plasmepsin II, an antimalarial-drug target
Angel Rafael Ramirez Ramirez
Biotechnology and Applied Biochemistry, 2009
View PDFchevron_right
Functional, structural, and immunological compartmentalisation of malaria invasive proteins
LUIS VARGAS
Biochemical and Biophysical Research Communications, 2007
View PDFchevron_right
Irreversible effect of cysteine protease inhibitors on the release of malaria parasites from infected erythrocytes
Julia Mazar
Cellular Microbiology, 2009
View PDFchevron_right